Global Prescription Gastrointestinal Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 97

Published Date: 03 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The prescription drugs are widely used in the treatment of gastrointestinal disorders, crohn’s disease, ulcerative colitis, irritable bowel syndrome, diverticular disease, constipation, celiac disease, short bowel syndrome, diarrhea, intestinal obstruction and digestive enzyme disorders.

According to our (Global Info Research) latest study, the global Prescription Gastrointestinal Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Prescription Gastrointestinal Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Prescription Gastrointestinal Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Prescription Gastrointestinal Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Prescription Gastrointestinal Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Prescription Gastrointestinal Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prescription Gastrointestinal Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prescription Gastrointestinal Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Axcan Pharmaceuticals, Eisai, GlaxoSmithKline and Merck and  etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Prescription Gastrointestinal Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Oral
    Topical

Market segment by Application
    Hospital Pharmacies
    Online Pharmacies
    Retail Pharmacies

Major players covered
    AstraZeneca
    Axcan Pharmaceuticals
    Eisai
    GlaxoSmithKline
    Merck
    Salix Pharmaceuticals

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prescription Gastrointestinal Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prescription Gastrointestinal Drugs, with price, sales, revenue and global market share of Prescription Gastrointestinal Drugs from 2018 to 2023.
Chapter 3, the Prescription Gastrointestinal Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prescription Gastrointestinal Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Prescription Gastrointestinal Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prescription Gastrointestinal Drugs.
Chapter 14 and 15, to describe Prescription Gastrointestinal Drugs sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Prescription Gastrointestinal Drugs
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Prescription Gastrointestinal Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Oral
        1.3.3 Topical
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Prescription Gastrointestinal Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital Pharmacies
        1.4.3 Online Pharmacies
        1.4.4 Retail Pharmacies
    1.5 Global Prescription Gastrointestinal Drugs Market Size & Forecast
        1.5.1 Global Prescription Gastrointestinal Drugs Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Prescription Gastrointestinal Drugs Sales Quantity (2018-2029)
        1.5.3 Global Prescription Gastrointestinal Drugs Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 AstraZeneca
        2.1.1 AstraZeneca Details
        2.1.2 AstraZeneca Major Business
        2.1.3 AstraZeneca Prescription Gastrointestinal Drugs Product and Services
        2.1.4 AstraZeneca Prescription Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 AstraZeneca Recent Developments/Updates
    2.2 Axcan Pharmaceuticals
        2.2.1 Axcan Pharmaceuticals Details
        2.2.2 Axcan Pharmaceuticals Major Business
        2.2.3 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product and Services
        2.2.4 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Axcan Pharmaceuticals Recent Developments/Updates
    2.3 Eisai
        2.3.1 Eisai Details
        2.3.2 Eisai Major Business
        2.3.3 Eisai Prescription Gastrointestinal Drugs Product and Services
        2.3.4 Eisai Prescription Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Eisai Recent Developments/Updates
    2.4 GlaxoSmithKline
        2.4.1 GlaxoSmithKline Details
        2.4.2 GlaxoSmithKline Major Business
        2.4.3 GlaxoSmithKline Prescription Gastrointestinal Drugs Product and Services
        2.4.4 GlaxoSmithKline Prescription Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 GlaxoSmithKline Recent Developments/Updates
    2.5 Merck
        2.5.1 Merck Details
        2.5.2 Merck Major Business
        2.5.3 Merck Prescription Gastrointestinal Drugs Product and Services
        2.5.4 Merck Prescription Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Merck Recent Developments/Updates
    2.6 Salix Pharmaceuticals
        2.6.1 Salix Pharmaceuticals Details
        2.6.2 Salix Pharmaceuticals Major Business
        2.6.3 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product and Services
        2.6.4 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Salix Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Prescription Gastrointestinal Drugs by Manufacturer
    3.1 Global Prescription Gastrointestinal Drugs Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Prescription Gastrointestinal Drugs Revenue by Manufacturer (2018-2023)
    3.3 Global Prescription Gastrointestinal Drugs Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Prescription Gastrointestinal Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Prescription Gastrointestinal Drugs Manufacturer Market Share in 2022
        3.4.2 Top 6 Prescription Gastrointestinal Drugs Manufacturer Market Share in 2022
    3.5 Prescription Gastrointestinal Drugs Market: Overall Company Footprint Analysis
        3.5.1 Prescription Gastrointestinal Drugs Market: Region Footprint
        3.5.2 Prescription Gastrointestinal Drugs Market: Company Product Type Footprint
        3.5.3 Prescription Gastrointestinal Drugs Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Prescription Gastrointestinal Drugs Market Size by Region
        4.1.1 Global Prescription Gastrointestinal Drugs Sales Quantity by Region (2018-2029)
        4.1.2 Global Prescription Gastrointestinal Drugs Consumption Value by Region (2018-2029)
        4.1.3 Global Prescription Gastrointestinal Drugs Average Price by Region (2018-2029)
    4.2 North America Prescription Gastrointestinal Drugs Consumption Value (2018-2029)
    4.3 Europe Prescription Gastrointestinal Drugs Consumption Value (2018-2029)
    4.4 Asia-Pacific Prescription Gastrointestinal Drugs Consumption Value (2018-2029)
    4.5 South America Prescription Gastrointestinal Drugs Consumption Value (2018-2029)
    4.6 Middle East and Africa Prescription Gastrointestinal Drugs Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Prescription Gastrointestinal Drugs Sales Quantity by Type (2018-2029)
    5.2 Global Prescription Gastrointestinal Drugs Consumption Value by Type (2018-2029)
    5.3 Global Prescription Gastrointestinal Drugs Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Prescription Gastrointestinal Drugs Sales Quantity by Application (2018-2029)
    6.2 Global Prescription Gastrointestinal Drugs Consumption Value by Application (2018-2029)
    6.3 Global Prescription Gastrointestinal Drugs Average Price by Application (2018-2029)

7 North America
    7.1 North America Prescription Gastrointestinal Drugs Sales Quantity by Type (2018-2029)
    7.2 North America Prescription Gastrointestinal Drugs Sales Quantity by Application (2018-2029)
    7.3 North America Prescription Gastrointestinal Drugs Market Size by Country
        7.3.1 North America Prescription Gastrointestinal Drugs Sales Quantity by Country (2018-2029)
        7.3.2 North America Prescription Gastrointestinal Drugs Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Prescription Gastrointestinal Drugs Sales Quantity by Type (2018-2029)
    8.2 Europe Prescription Gastrointestinal Drugs Sales Quantity by Application (2018-2029)
    8.3 Europe Prescription Gastrointestinal Drugs Market Size by Country
        8.3.1 Europe Prescription Gastrointestinal Drugs Sales Quantity by Country (2018-2029)
        8.3.2 Europe Prescription Gastrointestinal Drugs Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Prescription Gastrointestinal Drugs Market Size by Region
        9.3.1 Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Prescription Gastrointestinal Drugs Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Prescription Gastrointestinal Drugs Sales Quantity by Type (2018-2029)
    10.2 South America Prescription Gastrointestinal Drugs Sales Quantity by Application (2018-2029)
    10.3 South America Prescription Gastrointestinal Drugs Market Size by Country
        10.3.1 South America Prescription Gastrointestinal Drugs Sales Quantity by Country (2018-2029)
        10.3.2 South America Prescription Gastrointestinal Drugs Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Prescription Gastrointestinal Drugs Market Size by Country
        11.3.1 Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Prescription Gastrointestinal Drugs Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Prescription Gastrointestinal Drugs Market Drivers
    12.2 Prescription Gastrointestinal Drugs Market Restraints
    12.3 Prescription Gastrointestinal Drugs Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Prescription Gastrointestinal Drugs and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Prescription Gastrointestinal Drugs
    13.3 Prescription Gastrointestinal Drugs Production Process
    13.4 Prescription Gastrointestinal Drugs Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Prescription Gastrointestinal Drugs Typical Distributors
    14.3 Prescription Gastrointestinal Drugs Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Prescription Gastrointestinal Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Prescription Gastrointestinal Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 4. AstraZeneca Major Business
    Table 5. AstraZeneca Prescription Gastrointestinal Drugs Product and Services
    Table 6. AstraZeneca Prescription Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. AstraZeneca Recent Developments/Updates
    Table 8. Axcan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 9. Axcan Pharmaceuticals Major Business
    Table 10. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product and Services
    Table 11. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Axcan Pharmaceuticals Recent Developments/Updates
    Table 13. Eisai Basic Information, Manufacturing Base and Competitors
    Table 14. Eisai Major Business
    Table 15. Eisai Prescription Gastrointestinal Drugs Product and Services
    Table 16. Eisai Prescription Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Eisai Recent Developments/Updates
    Table 18. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 19. GlaxoSmithKline Major Business
    Table 20. GlaxoSmithKline Prescription Gastrointestinal Drugs Product and Services
    Table 21. GlaxoSmithKline Prescription Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. GlaxoSmithKline Recent Developments/Updates
    Table 23. Merck Basic Information, Manufacturing Base and Competitors
    Table 24. Merck Major Business
    Table 25. Merck Prescription Gastrointestinal Drugs Product and Services
    Table 26. Merck Prescription Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Merck Recent Developments/Updates
    Table 28. Salix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 29. Salix Pharmaceuticals Major Business
    Table 30. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product and Services
    Table 31. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Salix Pharmaceuticals Recent Developments/Updates
    Table 33. Global Prescription Gastrointestinal Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 34. Global Prescription Gastrointestinal Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 35. Global Prescription Gastrointestinal Drugs Average Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 36. Market Position of Manufacturers in Prescription Gastrointestinal Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 37. Head Office and Prescription Gastrointestinal Drugs Production Site of Key Manufacturer
    Table 38. Prescription Gastrointestinal Drugs Market: Company Product Type Footprint
    Table 39. Prescription Gastrointestinal Drugs Market: Company Product Application Footprint
    Table 40. Prescription Gastrointestinal Drugs New Market Entrants and Barriers to Market Entry
    Table 41. Prescription Gastrointestinal Drugs Mergers, Acquisition, Agreements, and Collaborations
    Table 42. Global Prescription Gastrointestinal Drugs Sales Quantity by Region (2018-2023) & (K Units)
    Table 43. Global Prescription Gastrointestinal Drugs Sales Quantity by Region (2024-2029) & (K Units)
    Table 44. Global Prescription Gastrointestinal Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 45. Global Prescription Gastrointestinal Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 46. Global Prescription Gastrointestinal Drugs Average Price by Region (2018-2023) & (USD/Unit)
    Table 47. Global Prescription Gastrointestinal Drugs Average Price by Region (2024-2029) & (USD/Unit)
    Table 48. Global Prescription Gastrointestinal Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 49. Global Prescription Gastrointestinal Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 50. Global Prescription Gastrointestinal Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 51. Global Prescription Gastrointestinal Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 52. Global Prescription Gastrointestinal Drugs Average Price by Type (2018-2023) & (USD/Unit)
    Table 53. Global Prescription Gastrointestinal Drugs Average Price by Type (2024-2029) & (USD/Unit)
    Table 54. Global Prescription Gastrointestinal Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 55. Global Prescription Gastrointestinal Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 56. Global Prescription Gastrointestinal Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 57. Global Prescription Gastrointestinal Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 58. Global Prescription Gastrointestinal Drugs Average Price by Application (2018-2023) & (USD/Unit)
    Table 59. Global Prescription Gastrointestinal Drugs Average Price by Application (2024-2029) & (USD/Unit)
    Table 60. North America Prescription Gastrointestinal Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 61. North America Prescription Gastrointestinal Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 62. North America Prescription Gastrointestinal Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 63. North America Prescription Gastrointestinal Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 64. North America Prescription Gastrointestinal Drugs Sales Quantity by Country (2018-2023) & (K Units)
    Table 65. North America Prescription Gastrointestinal Drugs Sales Quantity by Country (2024-2029) & (K Units)
    Table 66. North America Prescription Gastrointestinal Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 67. North America Prescription Gastrointestinal Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 68. Europe Prescription Gastrointestinal Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 69. Europe Prescription Gastrointestinal Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 70. Europe Prescription Gastrointestinal Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 71. Europe Prescription Gastrointestinal Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 72. Europe Prescription Gastrointestinal Drugs Sales Quantity by Country (2018-2023) & (K Units)
    Table 73. Europe Prescription Gastrointestinal Drugs Sales Quantity by Country (2024-2029) & (K Units)
    Table 74. Europe Prescription Gastrointestinal Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 75. Europe Prescription Gastrointestinal Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 76. Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 77. Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 78. Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 79. Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 80. Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity by Region (2018-2023) & (K Units)
    Table 81. Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity by Region (2024-2029) & (K Units)
    Table 82. Asia-Pacific Prescription Gastrointestinal Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 83. Asia-Pacific Prescription Gastrointestinal Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 84. South America Prescription Gastrointestinal Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 85. South America Prescription Gastrointestinal Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 86. South America Prescription Gastrointestinal Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 87. South America Prescription Gastrointestinal Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 88. South America Prescription Gastrointestinal Drugs Sales Quantity by Country (2018-2023) & (K Units)
    Table 89. South America Prescription Gastrointestinal Drugs Sales Quantity by Country (2024-2029) & (K Units)
    Table 90. South America Prescription Gastrointestinal Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 91. South America Prescription Gastrointestinal Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 92. Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 93. Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 94. Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 95. Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 96. Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity by Region (2018-2023) & (K Units)
    Table 97. Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity by Region (2024-2029) & (K Units)
    Table 98. Middle East & Africa Prescription Gastrointestinal Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 99. Middle East & Africa Prescription Gastrointestinal Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 100. Prescription Gastrointestinal Drugs Raw Material
    Table 101. Key Manufacturers of Prescription Gastrointestinal Drugs Raw Materials
    Table 102. Prescription Gastrointestinal Drugs Typical Distributors
    Table 103. Prescription Gastrointestinal Drugs Typical Customers
List of Figures
    Figure 1. Prescription Gastrointestinal Drugs Picture
    Figure 2. Global Prescription Gastrointestinal Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Prescription Gastrointestinal Drugs Consumption Value Market Share by Type in 2022
    Figure 4. Oral Examples
    Figure 5. Topical Examples
    Figure 6. Global Prescription Gastrointestinal Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Prescription Gastrointestinal Drugs Consumption Value Market Share by Application in 2022
    Figure 8. Hospital Pharmacies Examples
    Figure 9. Online Pharmacies Examples
    Figure 10. Retail Pharmacies Examples
    Figure 11. Global Prescription Gastrointestinal Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Prescription Gastrointestinal Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Prescription Gastrointestinal Drugs Sales Quantity (2018-2029) & (K Units)
    Figure 14. Global Prescription Gastrointestinal Drugs Average Price (2018-2029) & (USD/Unit)
    Figure 15. Global Prescription Gastrointestinal Drugs Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global Prescription Gastrointestinal Drugs Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of Prescription Gastrointestinal Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Prescription Gastrointestinal Drugs Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 Prescription Gastrointestinal Drugs Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global Prescription Gastrointestinal Drugs Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global Prescription Gastrointestinal Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America Prescription Gastrointestinal Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Prescription Gastrointestinal Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Prescription Gastrointestinal Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Prescription Gastrointestinal Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa Prescription Gastrointestinal Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Prescription Gastrointestinal Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global Prescription Gastrointestinal Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global Prescription Gastrointestinal Drugs Average Price by Type (2018-2029) & (USD/Unit)
    Figure 30. Global Prescription Gastrointestinal Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 31. Global Prescription Gastrointestinal Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 32. Global Prescription Gastrointestinal Drugs Average Price by Application (2018-2029) & (USD/Unit)
    Figure 33. North America Prescription Gastrointestinal Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America Prescription Gastrointestinal Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 35. North America Prescription Gastrointestinal Drugs Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America Prescription Gastrointestinal Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe Prescription Gastrointestinal Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe Prescription Gastrointestinal Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 42. Europe Prescription Gastrointestinal Drugs Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe Prescription Gastrointestinal Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific Prescription Gastrointestinal Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America Prescription Gastrointestinal Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America Prescription Gastrointestinal Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 61. South America Prescription Gastrointestinal Drugs Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America Prescription Gastrointestinal Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 67. Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa Prescription Gastrointestinal Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Prescription Gastrointestinal Drugs Market Drivers
    Figure 74. Prescription Gastrointestinal Drugs Market Restraints
    Figure 75. Prescription Gastrointestinal Drugs Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Prescription Gastrointestinal Drugs in 2022
    Figure 78. Manufacturing Process Analysis of Prescription Gastrointestinal Drugs
    Figure 79. Prescription Gastrointestinal Drugs Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

AstraZeneca
Axcan Pharmaceuticals
Eisai
GlaxoSmithKline
Merck
Salix Pharmaceuticals

Related Reports

Global Prescription Gastrointestinal Drugs Supply, Demand and Key Producers, 2023-2029

Global Prescription Gastrointestinal Drugs Supply, Demand and Key Producers, 2023-2029

date 27 Feb 2023

date Pharma & Healthcare

The prescription drugs are widely used in the treatment of gastrointestinal disorders, crohn’s disease, ulcerative colitis, irritable bowel syndrome, diverticular disease, constipation, celiac disease, short bowel syndrome, diarrhea, intestinal obstruction and digestive enzyme disorders.

Global Prescription Gastrointestinal Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Prescription Gastrointestinal Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Prescription Gastrointestinal Drugs market size was valued at USD 29640 million in 2023 and is forecast to a readjusted size of USD 42180 million by 2030 with a CAGR of 5.2% during review period.

Product Tags

Prescription Gastrointestinal Drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>